Hyperglycemia induced cell growth and gene expression via the serum response element through rhoa and rho-kinase in vascular smooth muscle cells

Preparative Biochemistry and Biotechnology

Volumn 40, Issue 2, 2010, Pages 139-151

  Ishiko, Kai ^a   Sakoda, Tsuyoshi ^a   Akagami, Takahumi ^a   Naka, Toshio ^a   Doi, Takashi ^a   Tsujino, Takeshi ^a   Masuyama, Tohru ^a   Ohyanagi, Mitsumasa ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

C fos sre; Gene expression; Hyperglycemia; Rat aortic smooth muscle cells; RhoA Rho kinase

Indexed keywords

RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; METABOLISM; RAT; SERUM RESPONSIVE ELEMENT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPERGLYCEMIA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SERUM RESPONSE ELEMENT; SIGNAL TRANSDUCTION;

RATTUS;

EID: 77749280011     PISSN: 10826068     EISSN: 15322297     Source Type: Journal    
DOI: 10.1080/10826060903558927     Document Type: Article

References (36)

1. Colwell, J. Vascular thrombosis in type II diabetes mellitus. Diabetes 1993, 42, 8-11.
2. Fruchart, J.C.; Nierman, M.C.; Stroes, E.S.; Kastelein, J.J.; Duriez, P. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004, 109, 15-19.
3. Laakso, M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999, 48, 937-942.
4. Park, S.H.; Maeso, S.P.; Zhou, Z.; Foroudi, F.; Topol, E.J.; Lincoff, A.M. Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus. Circulation 2001, 104, 815-819.
5. Yoshida, Y.; Ohyanagi, M.; Iwasaki, T. Chronological changes of a-adrenoceptor-mediated vascular constriction on Otsuka-Long-Evans-Tokushima fatty rats. Hypertens. Res. 2003, 26, 559-567.
6. Kornowski, R.; Mintz, G.S.; Kent, K.M. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997, 95, 1366-1369.
7. Takai, Y.; Sasaki, T.; Matozaki, T. Small GTP-binding proteins. Physiol. Rev. 2001, 81, 153-208.
8. Uehata, M.; Ishizaki, T.; Satoh, H. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389, 990-994.
9. Miyagi, Y.; Carpenter, R.C.; Meguro, T.; Parent, A.D.; Zhang, J.H. Upregulation of rhoA and rho kinase messenger RNAs in the basilar artery of a rat model of subarachnoid hemorrhage. J. Neurosurg. 2000, 93, 471-476.
10. Hoshijima, M.; Sah, V.P.; Wang, Y.; Chien, K.R.; Brown, J.H. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase. J. Biol. Chem. 1998, 27, 7725-7730.
11. Ueyama, T.; Sakoda, T.; Kawashima, S. Activated RhoA stimulates c-fos gene expression in myocardial cells. Circ. Res. 1997, 81, 672-678.
12. Vaughan, C.J.; Murphy, M.B.; Buckley, B.M. Statins do more than just lower cholesterol. Lancet 1996, 348, 1079-1082.
13. Duriez, P. Current practice in the treatment of hyperlipidemias. Expert Opin. Pharmacother. 2001, 2, 1777-1794.
14. Amano, M.; Fukata, Y.; Kaibuchi, K. Regulation and functions of Rho-associated kinase. Exp. Cell Res. 2000, 261, 44-51.
15. Gong, M.C.; Iizuka, K.; Nixon, G. Role of guanine nucleotide-binding proteins-ras-family or trimeric proteins or both-in Ca sensitization of smooth muscle. Proc. Natl. Acad. Sci. USA 1996, 93, 1340-1345.
16. Masumoto, A.; Hirooka, Y.; Shimokawa, H.; Hironaga, K.; Setoguchi, S.; Takeshita, A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 2001, 38, 1307-1310.
17. Masumoto, A.; Mohri, M.; Shimokawa, H.; Urakami, I.; Usui, M.; Takeshita, A. Suppression of coronary artery spasm by Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002, 105, 1545-1547.
18. Kataoka, C.; Egashira, K.; Inoue, S. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide sysnthesis in rats. Hypetnesion 2002, 39, 245-250.
19. Miyata, K.; Shimokawa, H.; Kandabashi, T. Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 2351-2358.
20. Chihara, K.; Amano, M.; Nakmura, N. Cytoskeletal rearrangements and transcriptional activation of c-fos serum response element by Rho-kinase. J. Biol. Chem. 1997, 40, 25121-25127.
21. Takahashi, T.; Taniguchi, H.; Konishi, U.; Kikkawa, Y.; Ishikawa, Y.; Yokoyama, M. Activation of Akt/ protein kinase B after stimulation with angiotensin II in vascular smooth muscle cells. Am. J. Physiol. 1999, 276 (6Pt2), H1927-1934.
22. Sakoda, T.; Kaibuchi, K.; Kishi, K.; Takai, Y. smg/rap1/Krev-1 p21 s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells. Oncogene 1992, i, 1705-1711.
23. Rikitake, Y.; Liao, J.K. Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation 2005, 111, 3261-3268.
24. Miki, N.; Hamamori, Y.; Hirata, K. Transforming growth factor-b1 potentiated a1-adrenargic and stretch-induced c-fos mRNA expression in rat myocardial cells. Circ. Res. 1994, 75, 8-14.
25. Xi, X.P.; Graf, K.; Goetze, S.; Fleck, E.; Hsueh, W.A.; Law, R.E. Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 73-82.
26. Yu, S.M.; Tsai, S.Y.; Guh, J.H.; Ko, F.N.; Teng, C.M.; Ou, J.T. Mechanism of catecholamine-induced proliferation of vascular smooth muscle cells. Circulation 1996, 94, 547-554.
27. Tuck, M.L. Obesity, the sympathetic nervous system, and essential hypertension. Hypertension 1992, 19 (Suppl 1), 167-177.
28. Uehata, M.; Ishizaki, T.; Satoh, H.; Ono, T.; Kawahara, T.; Morishita, T. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389, 990-994.
29. van Nieuw Amerongen, G.P.; van Hinsbergh, V.W.M. Cytoskeletal effects of Rho-like small guanine nucleotide-binding proteins in the vascular system. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 300-311.
30. Horwitz, A.R.; Parsons, J.T. Cell migration: Movein' on. Science 1999, 286, 1102-1103.
31. Narumiya, S. The small GTPase Rho: cellular functions and signal transduction. J. Biochem. (Tokyo) 1996, 120, 215-228.
32. Kaibuchi, K.; Kuroda, S.; Amano, M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTP-ases in mammalian cells. Annu. Rev. Biochem. 1999, 68, 459-486.
33. Fukata, Y.; Amano, M.; Kaibuchi, K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 2001, 22, 32-39.
34. Takemoto, M.; Liao, J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1712-1719.
35. Sasaki, J.; Iwashita, M.; Kondo, S. Statins: Beneficial or adverse for glucose metabolism. J. Atheroscler. Thromb. 2006, 13, 23-29.
36. Danesh, F.R.; Kanwar, Y.S. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy. FASEB J. 2004, 18, 805-815.